Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1899817rdf:typepubmed:Citationlld:pubmed
pubmed-article:1899817lifeskim:mentionsumls-concept:C2709248lld:lifeskim
pubmed-article:1899817lifeskim:mentionsumls-concept:C0042396lld:lifeskim
pubmed-article:1899817lifeskim:mentionsumls-concept:C0036421lld:lifeskim
pubmed-article:1899817lifeskim:mentionsumls-concept:C0242184lld:lifeskim
pubmed-article:1899817lifeskim:mentionsumls-concept:C0152171lld:lifeskim
pubmed-article:1899817pubmed:issue3lld:pubmed
pubmed-article:1899817pubmed:dateCreated1991-3-28lld:pubmed
pubmed-article:1899817pubmed:abstractTextReduction of pulmonary vascular resistance by a high inspired oxygen concentration is a common, but not universal phenomenon in patients with pulmonary vascular disease of varying etiology that may determine their response to long-term domiciliary oxygen therapy. We therefore determined changes in PVR during oxygen therapy in two patient populations not previously studied: systemic sclerosis (n = 8, mean age +/- SEM, 44.5 +/- 5.4 years) and primary pulmonary hypertension (n = 7, mean age +/- SEM 38 +/- 7.8 years). All patients were hypoxemic (arterial oxygen tension, on air 9.5 +/- 1.2 kPa for SSc and 8.3 +/- 0.6 kPa for PPH, p greater than 0.05). Right atrial pressure, pulmonary artery pressure, pulmonary artery occlusion pressure, systemic arterial pressure, PaO2 and cardiac output by thermodilution were measured at three, 20-min intervals while inspiring air and again after inspiring 60 percent oxygen for 30 min. The PVR fell significantly with oxygen in patients with SSc from 797.6 +/- 179.2 to 610 +/- 151.6 dynes/s/cm-5 (p less than 0.01), and this fall correlated with baseline PAP and PaO2 prior to oxygen therapy (r = 0.86, p less than 0.025; r = 0.77, p less than 0.05, respectively). In patients with PPH, there was no significant fall in PVR with oxygen (from 969 +/- 80.2 to 851.9 +/- 91.2 dynes/s/cm-5, p greater than 0.05) and no predictor of a vasodilator response in individual patients. In SSc, hypoxic pulmonary vasoconstriction contributes more consistently to elevated PVR than in patients with PPH.lld:pubmed
pubmed-article:1899817pubmed:languageenglld:pubmed
pubmed-article:1899817pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1899817pubmed:citationSubsetAIMlld:pubmed
pubmed-article:1899817pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1899817pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1899817pubmed:statusMEDLINElld:pubmed
pubmed-article:1899817pubmed:monthMarlld:pubmed
pubmed-article:1899817pubmed:issn0012-3692lld:pubmed
pubmed-article:1899817pubmed:authorpubmed-author:GriffithsMMlld:pubmed
pubmed-article:1899817pubmed:authorpubmed-author:MorganJ MJMlld:pubmed
pubmed-article:1899817pubmed:authorpubmed-author:EvansT WTWlld:pubmed
pubmed-article:1899817pubmed:authorpubmed-author:du BoisR MRMlld:pubmed
pubmed-article:1899817pubmed:issnTypePrintlld:pubmed
pubmed-article:1899817pubmed:volume99lld:pubmed
pubmed-article:1899817pubmed:ownerNLMlld:pubmed
pubmed-article:1899817pubmed:authorsCompleteYlld:pubmed
pubmed-article:1899817pubmed:pagination551-6lld:pubmed
pubmed-article:1899817pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:1899817pubmed:meshHeadingpubmed-meshheading:1899817-...lld:pubmed
pubmed-article:1899817pubmed:meshHeadingpubmed-meshheading:1899817-...lld:pubmed
pubmed-article:1899817pubmed:meshHeadingpubmed-meshheading:1899817-...lld:pubmed
pubmed-article:1899817pubmed:meshHeadingpubmed-meshheading:1899817-...lld:pubmed
pubmed-article:1899817pubmed:meshHeadingpubmed-meshheading:1899817-...lld:pubmed
pubmed-article:1899817pubmed:meshHeadingpubmed-meshheading:1899817-...lld:pubmed
pubmed-article:1899817pubmed:meshHeadingpubmed-meshheading:1899817-...lld:pubmed
pubmed-article:1899817pubmed:meshHeadingpubmed-meshheading:1899817-...lld:pubmed
pubmed-article:1899817pubmed:meshHeadingpubmed-meshheading:1899817-...lld:pubmed
pubmed-article:1899817pubmed:meshHeadingpubmed-meshheading:1899817-...lld:pubmed
pubmed-article:1899817pubmed:meshHeadingpubmed-meshheading:1899817-...lld:pubmed
pubmed-article:1899817pubmed:meshHeadingpubmed-meshheading:1899817-...lld:pubmed
pubmed-article:1899817pubmed:meshHeadingpubmed-meshheading:1899817-...lld:pubmed
pubmed-article:1899817pubmed:meshHeadingpubmed-meshheading:1899817-...lld:pubmed
pubmed-article:1899817pubmed:meshHeadingpubmed-meshheading:1899817-...lld:pubmed
pubmed-article:1899817pubmed:meshHeadingpubmed-meshheading:1899817-...lld:pubmed
pubmed-article:1899817pubmed:meshHeadingpubmed-meshheading:1899817-...lld:pubmed
pubmed-article:1899817pubmed:year1991lld:pubmed
pubmed-article:1899817pubmed:articleTitleHypoxic pulmonary vasoconstriction in systemic sclerosis and primary pulmonary hypertension.lld:pubmed
pubmed-article:1899817pubmed:affiliationDepartment of Thoracic Medicine, National Heart and Lung Institute, London, England.lld:pubmed
pubmed-article:1899817pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1899817pubmed:publicationTypeComparative Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1899817lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1899817lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1899817lld:pubmed